![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 09, 2014 5:12:49 PM
I thought there was going to be a date announced a week or so ago for an ADCOM date if I remember correctly. That might push it up to 3? Or, at least 2.8ish? Or is that news already baked in to the price? Not sure, I have to review again.
From what I've found, there was a PR on their web site from Sep of last year(link: http://ir.enteromedics.com/releasedetail.cfm?ReleaseID=792796) stating, "We are very encouraged by the responsiveness of the FDA and are confident in our ability to address their questions in a timely manner," said Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer.
"We will continue to work closely with the FDA throughout this process. We believe that the Company continues on track for a panel in late Q4 2013/Q1 2014 with approval decision in the first half of 2014."
BiopharmCatalyst web site shows a date of: 3/31/14 - but I think that's a temp date. Anyone know?
link: http://www.biopharmcatalyst.com/fda-calendar/
Thanks
These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM